Context Therapeutics Inc (CNTX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.19-7.67%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · CNTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Operating Income | (48.7) | (39.7) | (29.9) | (25.1) | (15.4) | (10.5) | (2.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | — | 0.1 | 0.7 |
| Interest & Investment Income | 2.5 | 3.4 | 3.2 | 1.2 | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | (0.1) | (0.0) | 0.1 | 0.0 |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (46.0) | (36.1) | (26.7) | (24.0) | (14.8) | (10.5) | 6.6 |
| Per Share | |||||||
| Basic EPS | (0.48) | (0.38) | (0.46) | (1.50) | (0.93) | (3.69) | 3.07 |
| Diluted EPS | (0.48) | (0.38) | (0.46) | (1.50) | (0.93) | (3.69) | (3.96) |
| Basic Weighted Avg Shares | 95.2 | 95.2 | 58.4 | 16.0 | 16.0 | 2.8 | 0.3 |
| Diluted Weighted Avg Shares | 95.2 | 95.2 | 58.4 | 16.0 | 16.0 | 2.8 | 2.1 |
| Supplemental | |||||||
| EBITDA | — | (39.7) | (29.9) | (25.1) | (15.4) | (10.5) | — |
| EBIT | (48.7) | (39.7) | (29.9) | (25.1) | (15.4) | (10.5) | (2.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.